Multiple genetic variants predict the progression-free survival of bevacizumab plus chemotherapy in advanced ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multiple genetic variants predict the progression-free survival of bevacizumab plus chemotherapy in advanced ovarian cancer

Published:2021-09-03 Issue:35 Volume:100 Page:e27130
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Gao Jie,Li Fang,Liu Zihao,Huang Mengli,Chen Huoming,Liao Guoqing,Meng Jichang,Wang Qing,Zhao Hui,Li Chenxi,Ji Jing,Cai Shangli,Du Nan

Funder

Beijing Science and Technology Planning Project

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference33 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

3. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004

4. Incorporation of bevacizumab in the primary treatment of ovarian cancer;Burger;N Engl J Med,2011

5. Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: the AURELIA open-label randomized phase III trial;Pujade-Lauraine;J Clin Oncol,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-angiogenic therapy in ovarian cancer: Current understandings and prospects of precision medicine;Frontiers in Pharmacology;2023-03-07

2. Case report: Long-term clinical benefit of pyrotinib therapy following trastuzumab resistance in HER2-amplification recurrent mucinous ovarian carcinoma;Frontiers in Oncology;2022-12-22

3. Three-Dimensional Modelling of Ovarian Cancer: From Cell Lines to Organoids for Discovery and Personalized Medicine;Frontiers in Bioengineering and Biotechnology;2022-02-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3